Patents by Inventor Koichi Watashi

Koichi Watashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
    Publication number: 20230364111
    Abstract: Described herein are methods and compositions for treating viral infections.
    Type: Application
    Filed: October 7, 2021
    Publication date: November 16, 2023
    Applicants: MAX BioPharma, Inc., Japan as represented by Director-General of National Institute of Infectious Diseases
    Inventors: Farhad Parhami, Frank Stappenbeck, Koichi Watashi, Hirofumi Ohashi
  • NTCP Inhibitor
    Publication number: 20210061859
    Abstract: The present invention provides a sodium taurocholate cotransporting polypeptide (NTCP) inhibitor comprising a cyclic peptide having a Xw1-W-Xw2-W structure, wherein Xw1 and Xw2 are each independently T, S, I, L, or V, or a N-alkylamino acid thereof, or having a P-Xp1-Xp2-H structure, wherein Xp1 is any amino acid, and Xp2 is I, L, or V, or a N-alkylamino acid thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 11, 2019
    Publication date: March 4, 2021
    Inventors: Hiroaki Suga, Toby Passioura, Takaji Wakita, Koichi Watashi
  • Macrocycles
    Patent number: 10738084
    Abstract: The invention relates to cyclic compounds of general formula (I): wherein R1, R2 and R3 are as defined in the specification, and their use as pharmaceuticals.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: August 11, 2020
    Assignee: Sentry Therapeutics Limited
    Inventors: Michael Peel, Andrew Scribner, Koichi Watashi, Satomi Shimura
  • NOVEL MACROCYCLES
    Publication number: 20180186836
    Abstract: The invention relates to cyclic compounds of general formula (I): wherein R1, R2 and R3 are as defined in the specification, and their use as pharmaceuticals.
    Type: Application
    Filed: June 30, 2016
    Publication date: July 5, 2018
    Applicant: Cypra;os Limited
    Inventors: Michael Peel, Andrew Scribner, Koichi Watashi, Satomi Shimura
  • CYCLOSPORIN A-BINDING PROTEIN
    Publication number: 20110158908
    Abstract: Disclosed are: a composition and a method for the diagnosis and/or the treatment of a CSABP-related disease, the regulation of the proliferation of an RNA virus and the regulation of an RNA-metabolizing system, which targets a cyclosporin A-binding protein (CSABP); a method for the screening of a component that targets a CSABP; a composition and a method for the detection/inhibition of CsA, NS5B or cyclosphilin B by utilizing a CSABP; a promoter for a CSABP; a method for the screening of a substance capable of regulating the expression of a CSABP by utilizing the promoter; and a method for the determination of the occurrence or clinical stage of a CSABP-related disease.
    Type: Application
    Filed: August 22, 2008
    Publication date: June 30, 2011
    Applicant: Sapporo Medical University
    Inventors: Hiroeki Sahara, Yoko Mori, Nobuaki Takahashi, Noriyuki Sato, Fumio Sugawara, Kengo Sakaguchi, Kengo Morohashi, Kazuki Iwabata, Koichi Watashi, Kunitada Shimotohno, Kokichi Kikuchi, Wataru Tsutae, Hiroki Miyashita
  • Use of modified cyclosporins for the treatment of HCV disorders
    Patent number: 7968518
    Abstract: Disclosed are non-immunosuppressive cyclophilin-binding cyclosporins, e.g., of formula (I, Ia or II) as defined herein, having useful properties in the prevention of Hepatitis C infections.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: June 28, 2011
    Assignee: Novartis AG
    Inventors: Makoto Hijikata, Kunitada Shimotohno, Koichi Watashi
  • Use of modified cyclosporins for the treatment of hcv disorders
    Publication number: 20070275884
    Abstract: Disclosed are non-immunosuppressive cyclophilin-binding cyclosporins, e.g. of formula (I, Ia or II) as defined herein, having useful properties in the prevention or treatment of Hepatitis C infections.
    Type: Application
    Filed: September 2, 2004
    Publication date: November 29, 2007
    Inventors: Makoto Hijikata, Kunitada Shimotohno, Koichi Watashi